Impact of KRAS mutations in clinical features and survival in pancreatic cancer patients: a single institution experience

Inga, E.Perdomo Zaldivar, E.Gomez, M.Cano, T.Rodriguez Alonso, B.Oritz, M.Rodriguez Alonso, R.Toledano Fonseca, M.Rodriguez Ariza, A.Aranda, E.2025-01-072025-01-072019-07-010923-7534https://hdl.handle.net/10668/25518enImpact of KRAS mutations in clinical features and survival in pancreatic cancer patients: a single institution experienceconference outputopen access10.1093/annonc/mdz155.3411569-8041http://www.annalsofoncology.org/article/S0923753419308567/pdf475860200347